Back to funds
View filing
Tri Locum Partners LP
hedge fundUpdated 27 days agoManaged by Tri Locum Partners Lp • Latest filing Q2 2026
Portfolio value
$813.2M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
36.3%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $328.3M |
| Q2 2023 | $269.1M |
| Q3 2023 | $312.8M |
| Q4 2023 | $218.8M |
| Q1 2024 | $288.4M |
| Q2 2024 | $395.5M |
| Q3 2024 | $417.4M |
| Q4 2024 | $482.7M |
| Q1 2025 | $194.9M |
| Q2 2025 | $329.5M |
| Q3 2025 | $435.1M |
| Q4 2025 | $770.1M |
| Q1 2026 | $712.5M |
| Q2 2026 | $813.2M |
Top holdings
19 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | J JNJ JOHNSON & JOHNSON | $107.9M | 424.9K | 13.27% | — |
| 2 | V VRTX VERTEX PHARMACEUTICALS INC | $100.2M | 201.8K | 12.33% | — |
| 3 | L LLY ELI LILLY & CO | $91.8M | 76.5K | 11.29% | — |
| 4 | A ASND ASCENDIS PHARMA A/S | $69M | 258.7K | 8.49% | — |
| 5 | D DXCM DEXCOM INC | $55.3M | 820.5K | 6.80% | — |
| 6 | A AXSM AXSOME THERAPEUTICS INC. | $53.7M | 219.3K | 6.60% | — |
| 7 | J JAZZ JAZZ PHARMACEUTICALS PLC | $53.4M | 221.7K | 6.57% | — |
| 8 | E ELVN ENLIVEN THERAPEUTICS INC | $44M | 866.7K | 5.41% | — |
| 9 | A ARGX ARGENX SE | $38.6M | 41.6K | 4.75% | — |
| 10 | M MDGL MADRIGAL PHARMACEUTICALS INC | $36.7M | 68.3K | 4.51% | — |
| 11 | R RVMDW REVOLUTION MEDICINES INC | $28.4M | 151.8K | 3.50% | — |
| 12 | U UTHR UNITED THERAPEUTICS CORP DEL | $25.5M | 47.0K | 3.13% | — |
| 13 | T TEVJF TEVA PHARMACEUTICAL INDS LTD | $25.3M | 746.8K | 3.11% | — |
| 14 | T TARS TARSUS PHARMACEUTICALS INC | $20.7M | 328.3K | 2.54% | — |
| 15 | I ISRG INTUITIVE SURGICAL INC | $19.1M | 48.0K | 2.35% | — |
| 16 | C CYTK CYTOKINETICS INC | $16.5M | 194.0K | 2.03% | — |
| 17 | D DNTH DIANTHUS THERAPEUTICS INC | $11.8M | 120.7K | 1.45% | — |
| 18 | B BHPLF BETA BIONICS INC | $7.7M | 493.3K | 0.95% | — |
| 19 | D DFTX DEFINIUM THERAPEUTICS INC | $7.7M | 163.0K | 0.94% | — |